Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 4/20 | 0.69 |
| ▸ | CA1 | P00915 | 3/20 | 0.69 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.66 |
| ▸ | MEN1 | O00255 | 1/20 | 0.66 |
| ▸ | CRHBP | P24387 | 1/20 | 0.66 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.66 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.66 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.60 |
| ▸ | CA12 | O43570 | 1/20 | 0.60 |
| ▸ | CA9 | Q16790 | 1/20 | 0.60 |
| ▸ | USP2 | O75604 | 1/20 | 0.60 |
| ▸ | TP53 | P04637 | 1/20 | 0.60 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.60 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.60 |
| ▸ | NPC1 | O15118 | 1/20 | 0.58 |
| ▸ | FNTA | P49354 | 2/20 | 0.57 |
| ▸ | FNTB | P49356 | 2/20 | 0.57 |
| ▸ | PGGT1B | P53609 | 2/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9461939 | 1.00 | CA2 (0.69) | CA2CA1ALDH1A1MEN1CRHBP | |
| SCHEMBL1158033 | 1.00 | CA2 (0.69) | CA2CA1ALDH1A1MEN1CRHBP | |
| SCHEMBL6646636 | 0.98 | CA2 (0.67) | CA2CA1ALDH1A1MEN1CRHBP | |
| Lithium SCHEMBL6646645 | 0.98 | CA2 (0.67) | CA2CA1ALDH1A1MEN1CRHBP | |
| Water SCHEMBL28867161 | 0.98 | CA2 (0.67) | CA2CA1ALDH1A1MEN1CRHBP | |
| SCHEMBL4388419 | 0.88 | MEN1 (0.63) | CA2CA1ALDH1A1MEN1CRHBP | |
| SCHEMBL4388416 | 0.88 | MEN1 (0.63) | CA2CA1ALDH1A1MEN1CRHBP | |
| SCHEMBL9830237 | 0.88 | CA2 (0.70) | CA2CA1ALDH1A1MEN1CRHBP | |
| SCHEMBL9830233 | 0.88 | CA2 (0.70) | CA2CA1ALDH1A1MEN1CRHBP | |
| SCHEMBL9501077 | 0.88 | MEN1 (0.63) | CA2CA1ALDH1A1MEN1CRHBP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 151 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119504598-A | Method for preparing azlactone self-coupling body by converting amino acid by using sulfur hexafluoride | 国网安徽省电力有限公司电力科学研究院 | 2025-02-25 | — | — | CN | claimed |
| CN-115197311-B | Purification method of recombinant human interleukin 12 protein | 康立泰生物医药(青岛)有限公司 | 2024-10-22 | — | — | CN | claimed |
| US-20230192755-A1 | COMPOSITION CONTAINING NUCLEIC ACID OLIGOMER | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2023-06-22 | — | — | US | claimed |
| EP-4137501-A1 | COMPOSITION CONTAINING NUCLEIC ACID OLIGOMER | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2023-02-22 | — | — | EP | claimed |
| CN-115397831-A | Compositions comprising nucleic acid oligomers | 住友化学株式会社 | 2022-11-25 | — | — | CN | claimed |
| CN-115197311-A | Purification method of recombinant human interleukin 12 protein | 康立泰生物医药(青岛)有限公司 | 2022-10-18 | — | — | CN | claimed |
| CN-105749890-A | Chiral stationary phase prepared by taking cinchonidine-boc-amide as chiral selector as well as preparation method and application thereof | 河南科技学院 | 2016-07-13 | — | — | CN | claimed |
| CN-105642261-A | Chiral stationary phase prepared with cinchonine-Boc-amide as chiral selector and preparation method and application thereof | 河南科技学院 | 2016-06-08 | — | — | CN | claimed |
| CN-105561959-A | Chiral stationary phase prepared by taking quinine-tertiary butyl carbamate as a chiral selector and preparation method and application of chiral stationary phase | HENAN INST OF SCIENCE & TECH | 2016-05-11 | — | — | CN | claimed |
| CN-105498736-A | Chiral stationary phase prepared by taking quinindium-t-butyl carbamate as chirality selector as well as preparation method and application of chiral stationary phase | HENAN INST OF SCIENCE & TECH | 2016-04-20 | — | — | CN | claimed |
| US-20100130416-A1 | MODULATION OF ANGIOGENESIS BY A-BETA PEPTIDE FRAGMENTS | ARCHER PHARMACEUTICALS, INC. (US) | 2010-05-27 | — | — | US | claimed |
| WO-2009143489-A2 | MODULATION OF ANGIOGENESIS BY A-BETA PEPTIDE FRAGMENTS | ARCHER PHARMACEUTICALS, INC. (US) | 2009-11-26 | — | — | WO | claimed |
| WO-1998050031-A1 | INHIBITORS OF PROTEIN ISOPRENYL TRANSFERASES | UNIVERSITY OF PITTSBURGH (US) | 1998-11-12 | — | — | WO | claimed |
| CN-1036832-C | Composition containing a penem or carbapenem artibiotic and the use of the same | SANKYO CO (JP) | 1997-12-31 | — | — | CN | claimed |
| US-5284872-A | Nitrato alkanoic acid derivatives, methods for their production, pharmaceutical compositions containing the derivatives and medicinal uses thereof | SCHWARZ PHARMA AG (DE) | 1994-02-08 | — | — | US | claimed |
| EP-0226304-B1 | COMPOSITION CONTAINING A PENEM OR CARBAPENEM ANTIBIOTIC | SANKYO COMPANY LIMITED (JP) | 1991-08-28 | — | — | EP | claimed |
| US-4757066-A | Reduces renal toxicity | SANKYO COMPANY LIMITED (JP) | 1988-07-12 | — | — | US | claimed |
| EP-0226304-A1 | Composition containing a penem or carbapenem antibiotic | SANKYO COMPANY LIMITED (JP) | 1987-06-24 | — | — | EP | claimed |
| CN-86107574-A | Compositions containing penem or carbapenem antibiotics and their use | — | 1987-05-20 | — | — | CN | claimed |
| JP-62114969-A | — | — | None | — | — | JP | disclosed |
| JP-62114954-A | — | — | None | — | — | JP | disclosed |
| JP-6107602-A | — | — | None | — | — | JP | disclosed |
| CN-119504598-A | Method for preparing azlactone self-coupling body by converting amino acid by using sulfur hexafluoride | 国网安徽省电力有限公司电力科学研究院 | 2025-02-25 | — | — | CN | disclosed |
| CN-115197311-B | Purification method of recombinant human interleukin 12 protein | 康立泰生物医药(青岛)有限公司 | 2024-10-22 | — | — | CN | disclosed |
| EP-2911759-B1 | ELUTION OF BIOMOLECULES FROM MULTI-MODAL RESINS USING MES AND MOPS AS MOBILE PHASE MODIFIERS | GENZYME CORP (US) | 2024-07-17 | — | — | EP | disclosed |
| US-20230322842-A1 | COMPOSITION CONTAINING NUCLEIC ACID OLIGOMER | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2023-10-12 | — | — | US | disclosed |
| US-20230192755-A1 | COMPOSITION CONTAINING NUCLEIC ACID OLIGOMER | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2023-06-22 | — | — | US | disclosed |
| US-20230191368-A1 | Separation Matrix and Method of Separation | CYTIVA BIOPROCESS R&D AB (SE) | 2023-06-22 | — | — | US | disclosed |
| US-20230191368-A1 | Separation Matrix and Method of Separation | CYTIVA BIOPROCESS R&D AB (SE) | 2023-06-22 | — | — | US | disclosed |
| EP-3434681-B1 | CURCUMIN-BORON COMPLEX AND PHARMACEUTICAL CONTAINING SAME | JAPAN SCIENCE & TECH AGENCY (JP) | 2023-05-10 | — | — | EP | disclosed |
| US-11622916-B2 | Photocurable composition excellent in curing depth | SHOFU INC. (JP) | 2023-04-11 | — | — | US | disclosed |
| EP-4137501-A1 | COMPOSITION CONTAINING NUCLEIC ACID OLIGOMER | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2023-02-22 | — | — | EP | disclosed |
| CN-115397831-A | Compositions comprising nucleic acid oligomers | 住友化学株式会社 | 2022-11-25 | — | — | CN | disclosed |
| CN-115197311-A | Purification method of recombinant human interleukin 12 protein | 康立泰生物医药(青岛)有限公司 | 2022-10-18 | — | — | CN | disclosed |
| US-20220287919-A1 | PHOTOCURABLE COMPOSITION EXCELLENT IN CURING DEPTH | SHOFU INC. (JP) | 2022-09-15 | — | — | US | disclosed |
| EP-4056164-A1 | PHOTOCURABLE COMPOSITION EXCELLENT IN CURING DEPTH | Shofu Inc. (JP) | 2022-09-14 | — | — | EP | disclosed |
| CN-108728877-B | Copper plating bath and copper plating film | 上村工业株式会社 | 2022-07-05 | — | — | CN | disclosed |
| US-11248305-B2 | Copper electrolytic plating bath and copper electrolytic plating film | C. UYEMURA & CO., LTD. (JP) | 2022-02-15 | — | — | US | disclosed |
| US-11203747-B2 | Elution of biomolecules from multi-modal resins using MES and MOPS as mobile phase modifiers | GENZYME CORPORATION (US) | 2021-12-21 | — | — | US | disclosed |
| CN-112438905-B | Moisturizing and skin-brightening composition and application thereof | 澳思美日用化工（广州）有限公司 | 2021-09-07 | — | — | CN | disclosed |
| CN-112438905-A | Moisturizing and skin-brightening composition and application thereof | 澳思美日用化工（广州）有限公司 | 2021-03-05 | — | — | CN | disclosed |
| CN-108884112-B | Curcumin boron complex and medicine containing curcumin boron complex | 国立研究开发法人科学技术振兴机构 | 2021-03-02 | — | — | CN | disclosed |
| US-10676423-B2 | Structure and synthesis of highly fluorinated amino acid derivatives | THE BOARD OF REGENTS FOR OKLAHOMA STATE UNIVERSITY (US) | 2020-06-09 | — | — | US | disclosed |
| US-10669287-B2 | Curcumin-boron complex and pharmaceutical containing same | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2020-06-02 | — | — | US | disclosed |
| CN-111172135-A | Elution of biomolecules from multimodal resins using MES and MOPS as mobile phase modifiers | 建新公司 | 2020-05-19 | — | — | CN | disclosed |
| US-20200131493-A1 | ELUTION OF BIOMOLECULES FROM MULTI-MODAL RESINS USING MES AND MOPS AS MOBILE PHASE MODIFIERS | GENZYME CORPORATION (US) | 2020-04-30 | — | — | US | disclosed |
| US-20200123099-A1 | Structure and Synthesis of Highly Fluorinated Amino Acid Derivatives | UNIV OKLAHOMA STATE (US) | 2020-04-23 | — | — | US | disclosed |
| US-10626128-B2 | — | — | 2020-04-21 | — | — | US | disclosed |
| US-20190100537-A1 | CURCUMIN-BORON COMPLEX AND PHARMACEUTICAL CONTAINING SAME | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2019-04-04 | — | — | US | disclosed |
| EP-3170820-B1 | BENZOTHIAZOLE COMPOUND AND MEDICINE CONTAINING SAME | JAPAN SCIENCE & TECH AGENCY (JP) | 2019-02-20 | — | — | EP | disclosed |
| EP-3434681-A1 | CURCUMIN-BORON COMPLEX AND PHARMACEUTICAL CONTAINING SAME | Japan Science and Technology Agency (JP) | 2019-01-30 | — | — | EP | disclosed |
| CN-108884112-A | Curcumin boron complex and medicine containing curcumin boron complex | 国立研究开发法人科学技术振兴机构 | 2018-11-23 | — | — | CN | disclosed |
| US-20180305833-A1 | COPPER ELECTROLYTIC PLATING BATH AND COPPER ELECTROLYTIC PLATING FILM | C. UYEMURA & CO., LTD. (JP) | 2018-10-25 | — | — | US | disclosed |
| WO-2018156500-A1 | STRUCTURE AND SYNTHESIS OF HIGHLY FLUORINATED AMINO ACID DERIVATIVES | THE BOARD OF REGENTS FOR OKLAHOMA STATE UNIVERSITY (US) | 2018-08-30 | — | — | WO | disclosed |
| CN-108066364-A | Synthetic camel organ extract, its preparation method and application | 兰多夫·里姆施耐德 | 2018-05-25 | — | — | CN | disclosed |
| US-9932333-B2 | Benzothiazole compound and medicine containing same | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2018-04-03 | — | — | US | disclosed |
| EP-2356979-B1 | ANTI-WRINKLE AGENTS | POLA CHEM IND INC (JP) | 2017-10-25 | — | — | EP | disclosed |
| US-20170197956-A1 | BENZOTHIAZOLE COMPOUND AND MEDICINE CONTAINING SAME | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2017-07-13 | — | — | US | disclosed |
| EP-3173063-A1 | ANTI-WRINKLE AGENTS | Pola Chemical Industries Inc. (JP) | 2017-05-31 | — | — | EP | disclosed |
| EP-3170820-A1 | BENZOTHIAZOLE COMPOUND AND MEDICINE CONTAINING SAME | Japan Science and Technology Agency (JP) | 2017-05-24 | — | — | EP | disclosed |
| CN-104211756-B | 2 amino 1,3 propanediol derivative, its preparation, nanostructured, Plumbum removing activity and application | 首都医科大学 | 2017-03-01 | — | — | CN | disclosed |
| EP-2471774-B1 | Piperidinyl derivatives as modulators of chemokine receptor activity | BRISTOL MYERS SQUIBB CO (US) | 2016-08-24 | — | — | EP | disclosed |
| CN-105777862-A | Elution of biomolecules from multi-modal resins using MES and MOPS as mobile phase modifiers | 建新公司 | 2016-07-20 | — | — | CN | disclosed |
| CN-105749890-A | Chiral stationary phase prepared by taking cinchonidine-boc-amide as chiral selector as well as preparation method and application thereof | 河南科技学院 | 2016-07-13 | — | — | CN | disclosed |
| CN-105642261-A | Chiral stationary phase prepared with cinchonine-Boc-amide as chiral selector and preparation method and application thereof | 河南科技学院 | 2016-06-08 | — | — | CN | disclosed |
| CN-105561959-A | Chiral stationary phase prepared by taking quinine-tertiary butyl carbamate as a chiral selector and preparation method and application of chiral stationary phase | HENAN INST OF SCIENCE & TECH | 2016-05-11 | — | — | CN | disclosed |
| CN-105498736-A | Chiral stationary phase prepared by taking quinindium-t-butyl carbamate as chirality selector as well as preparation method and application of chiral stationary phase | HENAN INST OF SCIENCE & TECH | 2016-04-20 | — | — | CN | disclosed |
| US-20150275195-A1 | ELUTION OF BIOMOLECULES FROM MULTI-MODAL RESINS USING MES AND MOPS AS MOBILE PHASE MODIFIERS | GENZYME CORPORATION (US) | 2015-10-01 | — | — | US | disclosed |
| EP-2911759-A1 | ELUTION OF BIOMOLECULES FROM MULTI-MODAL RESINS USING MES AND MOPS AS MOBILE PHASE MODIFIERS | Genzyme Corporation (US) | 2015-09-02 | — | — | EP | disclosed |
| CN-104884147-A | Elution of Biomolecules from Multimodal Resins Using MES and MOPS as Mobile Phase Modifiers | GENZYME CORP | 2015-09-02 | — | — | CN | disclosed |
| US-8835498-B2 | Anti-wrinkle agents | POLA CHEMICAL INDUSTRIES INC. (JP) | 2014-09-16 | — | — | US | disclosed |
| CN-102215812-B | Anti-wrinkle agents | POLA CHEM IND INC | 2014-09-10 | — | — | CN | disclosed |
| WO-2014066471-A1 | ELUTION OF BIOMOLECULES FROM MULTI-MODAL RESINS USING MES AND MOPS AS MOBILE PHASE MODIFIERS | GENZYME CORPORATION (US) | 2014-05-01 | — | — | WO | disclosed |
| EP-2239335-B1 | PROCESS FOR PRODUCTION OF SERINE DERIVATIVE, AND PROTEIN FOR USE IN THE PROCESS | AJINOMOTO KK (JP) | 2013-02-27 | — | — | EP | disclosed |
| US-8372607-B2 | Method for producing serine derivative and protein used for the same | AJINOMOTO CO., INC. (JP) | 2013-02-12 | — | — | US | disclosed |
| EP-2471774-A1 | Piperidinyl derivatives as modulators of chemokine receptor activity | Bristol-Myers Squibb Company (US) | 2012-07-04 | — | — | EP | disclosed |
| CN-102215812-A | Anti-wrinkle agents | POLA CHEM IND INC | 2011-10-12 | — | — | CN | disclosed |
| US-20110245343-A1 | ANTI-WRINKLE AGENTS | POLA CHEMICAL INDUSTRIES INC. (JP) | 2011-10-06 | — | — | US | disclosed |
| US-20110245226-A1 | PIPERIDINYL DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY | BRISTOL-MYERS SQUIBB COMPANY | 2011-10-06 | — | — | US | disclosed |
| EP-2356979-A1 | ANTI-WRINKLE AGENTS | Pola Chemical Industries Inc. (JP) | 2011-08-17 | — | — | EP | disclosed |
| US-7985861-B2 | Piperidinyl derivatives as modulators of chemokine receptor activity | BRISTOL-MYERS SQUIBB COMPANY (US) | 2011-07-26 | — | — | US | disclosed |
| US-7888417-B2 | core or the layer includes a composition formed from a base polymer, a crosslink initiator, and at least one additive; additive has at least one carbon-oxygen-boron linkage, carbon in the linkage being a secondary or tertiary carbon; enhances coefficient of restitution and/or reduces compression of core | ACUSHNET COMPANY (US) | 2011-02-15 | — | — | US | disclosed |
| US-20100317068-A1 | METHOD FOR PRODUCING SERINE DERIVATIVE AND PROTEIN USED FOR THE SAME | AJINOMOTO CO., INC. (JP) | 2010-12-16 | — | — | US | disclosed |
| EP-2239335-A1 | PROCESS FOR PRODUCTION OF SERINE DERIVATIVE, AND PROTEIN FOR USE IN THE PROCESS | Ajinomoto Co., Inc. (JP) | 2010-10-13 | — | — | EP | disclosed |
| US-7750129-B2 | Process for the purification of antibodies | GE HEALTHCARE BIO-SCIENCES AB (SE) | 2010-07-06 | — | — | US | disclosed |
| US-20100130416-A1 | MODULATION OF ANGIOGENESIS BY A-BETA PEPTIDE FRAGMENTS | ARCHER PHARMACEUTICALS, INC. (US) | 2010-05-27 | — | — | US | disclosed |
| US-20090298833-A1 | PIPERIDINYL DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY | BRISTOL-MYERS SQUIBB COMPANY | 2009-12-03 | — | — | US | disclosed |
| WO-2009143489-A2 | MODULATION OF ANGIOGENESIS BY A-BETA PEPTIDE FRAGMENTS | ARCHER PHARMACEUTICALS, INC. (US) | 2009-11-26 | — | — | WO | disclosed |
| US-7601844-B2 | Piperidinyl derivatives as modulators of chemokine receptor activity | BRISTOL-MYERS SQUIBB COMPANY (US) | 2009-10-13 | — | — | US | disclosed |
| EP-2049486-A2 | PIPERIDINYL DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY | Bristol-Myers Squibb Company (US) | 2009-04-22 | — | — | EP | disclosed |
| US-7465471-B2 | Palatability of aquaculture feed | NOVUS INTERNATIONAL, INC. (US) | 2008-12-16 | — | — | US | disclosed |
| US-20080261722-A1 | COMPOSITIONS FOR USE IN GOLF BALLS | ACUSHNET COMPANY | 2008-10-23 | — | — | US | disclosed |
| US-20080227567-A1 | COMPOSITIONS FOR USE IN GOLF BALLS | ACUSHNET COMPANY | 2008-09-18 | — | — | US | disclosed |
| US-20080176678-A1 | Compositions for Use in Golf Balls | ACUSHNET COMPANY | 2008-07-24 | — | — | US | disclosed |
| US-7385040-B2 | contacting the solution with a chromatography resin containing a support to which multi-modal ligands have been immobilised ( N-hydroxysuccinimide activated agarose carrier coupled with 3-amino-4(propylsulfonyl)thiophene-2-carboxylic acid ligand) to adsorb antibodies and/or contaminants to the resin | GE HEALTHCARE BIO-SCIENCES AB (SE) | 2008-06-10 | — | — | US | disclosed |
| US-7361711-B2 | Compositions for use in golf balls | ACUSHNET COMPANY (US) | 2008-04-22 | — | — | US | disclosed |
| US-7358309-B2 | core or the layer includes a composition formed from a base polymer, a crosslink initiator, and at least one additive; additive has at least one carbon-oxygen-boron linkage, carbon in the linkage being a secondary or tertiary carbon; enhances coefficient of restitution and/or reduces compression of core | ACUSHNET COMPANY (US) | 2008-04-15 | — | — | US | disclosed |
| US-7358310-B2 | Compositions for use in golf balls | ACUSHNET COMPANY (US) | 2008-04-15 | — | — | US | disclosed |
| US-7358308-B2 | Compositions for use in golf balls | ACUSHNET COMPANY (US) | 2008-04-15 | — | — | US | disclosed |
| EP-1414432-A4 | METHODS OF USE FOR NOVEL SULFUR CONTAINING ORGANIC NITRATE COMPOUNDS | NITROMED INC (US) | 2008-01-09 | — | — | EP | disclosed |
| WO-2007147155-A1 | POLYOL ESTER COMPOUNDS | NOVUS INTERNATIONAL INC. (US) | 2007-12-21 | — | — | WO | disclosed |
| US-20070292485-A1 | POLYOL ESTER COMPOUNDS | NOVUS INTERNATIONAL INC. (US) | 2007-12-20 | — | — | US | disclosed |
| EP-1338588-B1 | METHOD OF RESOLVING OPTICAL ISOMERS OF AMINO ACID DERIVATIVE | TOKUYAMA CORP (JP) | 2007-09-26 | — | — | EP | disclosed |
| US-20070208056-A1 | PIPERIDINYL DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY | BRISTOL-MYERS SQUIBB COMPANY | 2007-09-06 | — | — | US | disclosed |
| WO-2007092681-A2 | PIPERIDINYL DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY | BRISTOL-MYERS SQUIBB COMPANY (US) | 2007-08-16 | — | — | WO | disclosed |
| US-20070167613-A1 | Process for the purification of antibodies | CYTIVA BIOPROCESS R&D AB (SE) | 2007-07-19 | — | — | US | disclosed |
| US-20070112178-A1 | contacting the solution with a chromatography resin containing a support to which multi-modal ligands have been immobilised ( N-hydroxysuccinimide activated agarose carrier coupled with 3-amino-4(propylsulfonyl)thiophene-2-carboxylic acid ligand) to adsorb antibodies and/or contaminants to the resin | CYTIVA BIOPROCESS R&D AB (SE) | 2007-05-17 | — | — | US | disclosed |
| US-7199264-B2 | Method of resolving optical isomers of amino acid derivative | TOKUYAMA CORPORATION (JP) | 2007-04-03 | — | — | US | disclosed |
| US-20060281586-A1 | Compositions for use in golf balls | JPMORGAN CHASE BANK, N.A., AS SUCCESSOR ADMINISTRATIVE AGENT | 2006-12-14 | — | — | US | disclosed |
| US-20060281587-A1 | Compositions for use in golf balls | JPMORGAN CHASE BANK, N.A., AS SUCCESSOR ADMINISTRATIVE AGENT | 2006-12-14 | — | — | US | disclosed |
| US-20050245652-A1 | Compositions for use in golf balls | JPMORGAN CHASE BANK, N.A., AS SUCCESSOR ADMINISTRATIVE AGENT | 2005-11-03 | — | — | US | disclosed |
| US-20050245657-A1 | Compositions for use in golf balls | JPMORGAN CHASE BANK, N.A., AS SUCCESSOR ADMINISTRATIVE AGENT | 2005-11-03 | — | — | US | disclosed |
| US-20050215623-A1 | Palatability of aquaculture feed | NOVUS INTERNATIONAL, INC. (US) | 2005-09-29 | — | — | US | disclosed |
| EP-1531672-A2 | ANTIMICROBIAL COMPOSITIONS | Novus International, Inc. (US) | 2005-05-25 | — | — | EP | disclosed |
| EP-0986384-A4 | INHIBITORS OF PROTEIN ISOPRENYL TRANSFERASES | UNIV PITTSBURGH (US) | 2004-09-15 | — | — | EP | disclosed |
| US-20040175434-A1 | Antimicrobial compositions | NOVUS INTERNATIONAL, INC. | 2004-09-09 | — | — | US | disclosed |
| US-20040152753-A1 | Methods of use for novel sulfur containing organic nitrate compounds | NITROMED, INC. | 2004-08-05 | — | — | US | disclosed |
| US-20040102646-A1 | Method of resolving optical isomers of amino acid derivative | TOKUYAMA CORPORATION (JP) | 2004-05-27 | — | — | US | disclosed |
| EP-1414432-A2 | METHODS OF USE FOR NOVEL SULFUR CONTAINING ORGANIC NITRATE COMPOUNDS | Nitromed, Inc. (US) | 2004-05-06 | — | — | EP | disclosed |
| WO-2004019683-A2 | ANTIMICROBIAL COMPOSITIONS | NOVUS INTERNATIONAL, INC. (US) | 2004-03-11 | — | — | WO | disclosed |
| EP-1338588-A1 | METHOD OF RESOLVING OPTICAL ISOMERS OF AMINO ACID DERIVATIVE | TOKUYAMA CORPORATION (JP) | 2003-08-27 | — | — | EP | disclosed |
| WO-2003013432-A2 | METHODS OF USE FOR NOVEL SULFUR CONTAINING ORGANIC NITRATE COMPOUNDS | NITROMED, INC. (US) | 2003-02-20 | — | — | WO | disclosed |
| EP-0986384-A1 | INHIBITORS OF PROTEIN ISOPRENYL TRANSFERASES | UNIVERSITY OF PITTSBURGH (US) | 2000-03-22 | — | — | EP | disclosed |
| US-6013501-A | POLYPEPTIDE WITH AMINO ACID HYDROLASE ACTIVITY; FOR SCREENING MODULATORS OF AMINO ACID HYDROLASE ENZME | CHAN VOON LOONG (CA) | 2000-01-11 | — | — | US | disclosed |
| US-5981189-A | CONTACTING THE SAMPLE WITH A NUCLEOTIDE PROBE CAPABLE OF HYBRIDIZING WITH NUCLEIC ACID SEQUENCE, DETECTING HYBRIDIZATION PRODUCT; DIAGNOSTIC TOOL IN DETECTION OF DIARRHEA FROM CAMPYLOBACTER | CHAN VOON LOONG (CA) | 1999-11-09 | — | — | US | disclosed |
| WO-1998050029-A1 | INHIBITORS OF PROTEIN ISOPRENYL TRANSFERASES | UNIVERSITY OF PITTSBURGH (US) | 1998-11-12 | — | — | WO | disclosed |
| US-5695960-A | Hippuricase gene | CHAN VOON LOONG (CA) | 1997-12-09 | — | — | US | disclosed |
| EP-0698104-B1 | HIPPURICASE GENE | CHAN VOON LOONG (CA) | 1997-10-01 | — | — | EP | disclosed |
| EP-0698104-A1 | HIPPURICASE GENE | CHAN VOON LOONG (CA) | 1996-02-28 | — | — | EP | disclosed |
| EP-0451760-B1 | Nitrato alkanoic acid derivatives and method for their production | SANOL ARZNEI SCHWARZ GMBH (DE) | 1995-09-13 | — | — | EP | disclosed |
| WO-1994026907-A1 | HIPPURICASE GENE | CHAN VOON LOONG (CA) | 1994-11-24 | — | — | WO | disclosed |
| JP-H06107602-A | PRODUCTION OF OPTICALLY ACTIVE 1-PHENYLETHYLAMINE | TORAY IND INC | 1994-04-19 | — | — | JP | disclosed |
| US-5284872-A | Nitrato alkanoic acid derivatives, methods for their production, pharmaceutical compositions containing the derivatives and medicinal uses thereof | SCHWARZ PHARMA AG (DE) | 1994-02-08 | — | — | US | disclosed |
| EP-0537185-A1 | AN ENZYMATIC PROCESS FOR THE PREPARATION OF DERIVATIVES OF GROWTH HORMONE RELEASING FACTOR AND PEPTIDES USEFUL AS INTERMEDIATES IN THE PROCESS | CARLBIOTECH LTD. A/S (DK) | 1993-04-21 | — | — | EP | disclosed |
| WO-1991018998-A1 | AN ENZYMATIC PROCESS FOR THE PREPARATION OF DERIVATIVES OF GROWTH HORMONE RELEASING FACTOR AND PEPTIDES USEFUL AS INTERMEDIATES IN THE PROCESS | CARLBIOTECH LTD. A/S (DK) | 1991-12-12 | — | — | WO | disclosed |
| EP-0451760-A1 | Nitrato alkanoic acid derivatives and method for their production | SCHWARZ PHARMA AG (DE) | 1991-10-16 | — | — | EP | disclosed |
| EP-0226304-B1 | COMPOSITION CONTAINING A PENEM OR CARBAPENEM ANTIBIOTIC | SANKYO COMPANY LIMITED (JP) | 1991-08-28 | — | — | EP | disclosed |
| EP-0245231-B1 | PROCESS FOR THE PREPARATION OF ALKYLTHIOALKANOATE SALTS | Monsanto Company (US) | 1990-09-12 | — | — | EP | disclosed |
| US-4883911-A | Process for the preparation of alkylthioalkanoate salts | MONSANTO COMPANY (US) | 1989-11-28 | — | — | US | disclosed |
| EP-0137371-B1 | PROCESS FOR THE RACEMISATION OF OPTICALLY ACTIVE AMINOACIDS | HOECHST AKTIENGESELLSCHAFT (DE) | 1989-05-31 | — | — | EP | disclosed |
| US-4777289-A | Process for the preparation of alkylthioalkanoate salts | MONSANTO COMPANY (US) | 1988-10-11 | — | — | US | disclosed |
| US-4757066-A | Reduces renal toxicity | SANKYO COMPANY LIMITED (JP) | 1988-07-12 | — | — | US | disclosed |
| EP-0245231-A1 | Process for the preparation of alkylthioalkanoate salts | Monsanto Company (US) | 1987-11-11 | — | — | EP | disclosed |
| EP-0134561-B1 | ALPHA-ALLENIC-ALPHA-AMINO ACIDS | SYNTEX (U.S.A.) INC. (US) | 1987-07-08 | — | — | EP | disclosed |
| EP-0226304-A1 | Composition containing a penem or carbapenem antibiotic | SANKYO COMPANY LIMITED (JP) | 1987-06-24 | — | — | EP | disclosed |
| JP-S62114969-A | PRODUCTION OF OPTICALLY ACTIVE ALPHA-AMINO-EPSILON-CAPROLACTAM | TORAY IND INC | 1987-05-26 | — | — | JP | disclosed |
| JP-S62114954-A | METHOD OF OPTICAL RESOLUTION OF N-BENZOYL-DL-METHIONINE | TORAY IND INC | 1987-05-26 | — | — | JP | disclosed |
| US-4661510-A | FUNGICIDES | SYNTEX (U.S.A.) INC. (US) | 1987-04-28 | — | — | US | disclosed |
| US-4638086-A | BENZOIC OR PHENYLACETIC ACID OR DERIVATIVES | HOECHST AKTIENGESELLSCHAFT (DE) | 1987-01-20 | — | — | US | disclosed |
| EP-0137371-A2 | Process for the racemisation of optically active aminoacids | HOECHST AKTIENGESELLSCHAFT (DE) | 1985-04-17 | — | — | EP | disclosed |
| EP-0134561-A1 | Alpha-allenic-alpha-amino acids | SYNTEX (U.S.A.) INC. (US) | 1985-03-20 | — | — | EP | disclosed |
| EP-0134561-A1 | Alpha-allenic-alpha-amino acids | SYNTEX (U.S.A.) INC. (US) | 1985-03-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (23 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070292485-A1 | POLYOL ESTER COMPOUNDS | PNLIP, ELOVL1, ELOVL5 | CA2 4221/4885CA1 2396/4885ALDH1A1 679/4885 |
| US-20040102646-A1 | Method of resolving optical isomers of amino acid derivative | ALAD, AAAS, BCAT1 | CA2 416/4885CA1 203/4885ALDH1A1 3448/4885 |
| US-20070112178-A1 | contacting the solution with a chromatography resin containing a support to which multi-modal ligands have been immobilised ( N-hydroxysuccinimide activated agarose carrier coupled with 3-amino-4(propylsulfonyl)thiophene-2-carboxylic acid ligand) to adsorb antibodies and/or contaminants to the resin | ATIC, ARSA, SLC7A1 | CA2 289/4885CA1 336/4885ALDH1A1 2587/4885 |
| US-20190100537-A1 | CURCUMIN-BORON COMPLEX AND PHARMACEUTICAL CONTAINING SAME | BACH1, BACE1, IAPP | CA2 581/4885CA1 184/4885ALDH1A1 1307/4885 |
| US-20090298833-A1 | PIPERIDINYL DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY | CCR1, CCR2, CCR3 | CA2 1930/4885CA1 1698/4885ALDH1A1 263/4885 |
| US-20200123099-A1 | Structure and Synthesis of Highly Fluorinated Amino Acid Derivatives | PFAS, BCAT2, SLC7A1 | CA2 1936/4885CA1 456/4885ALDH1A1 3892/4885 |
| US-20070208056-A1 | PIPERIDINYL DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY | CCR1, CCR2, CCR3 | CA2 1930/4885CA1 1698/4885ALDH1A1 263/4885 |
| US-20230192755-A1 | COMPOSITION CONTAINING NUCLEIC ACID OLIGOMER | NSUN2, RNGTT, NSUN3 | CA2 1746/4885CA1 2006/4885ALDH1A1 2039/4885 |
| US-11622916-B2 | Photocurable composition excellent in curing depth | ODC1, AOC2, CCNT1 | CA2 1321/4885CA1 1813/4885ALDH1A1 74/4885 |
| US-20100130416-A1 | MODULATION OF ANGIOGENESIS BY A-BETA PEPTIDE FRAGMENTS | VEGFA, APP, IAPP | CA2 3009/4885CA1 961/4885ALDH1A1 2501/4885 |
| US-20170197956-A1 | BENZOTHIAZOLE COMPOUND AND MEDICINE CONTAINING SAME | APP, BACE1, PSEN1 | CA2 2401/4885CA1 1309/4885ALDH1A1 881/4885 |
| US-10669287-B2 | Curcumin-boron complex and pharmaceutical containing same | BACH1, BACE1, IAPP | CA2 581/4885CA1 184/4885ALDH1A1 1307/4885 |
| US-20220287919-A1 | PHOTOCURABLE COMPOSITION EXCELLENT IN CURING DEPTH | ODC1, AOC2, CCNT1 | CA2 1338/4885CA1 1868/4885ALDH1A1 74/4885 |
| US-20230322842-A1 | COMPOSITION CONTAINING NUCLEIC ACID OLIGOMER | NSUN2, RNGTT, NSUN3 | CA2 1653/4885CA1 2068/4885ALDH1A1 2051/4885 |
| US-20040152753-A1 | Methods of use for novel sulfur containing organic nitrate compounds | PTGS2, NOS2, PTGS1 | CA2 179/4885CA1 2128/4885ALDH1A1 1983/4885 |
| US-20050215623-A1 | Palatability of aquaculture feed | TAS2R3, TAS2R1, TAS2R20 | CA2 3421/4885CA1 4589/4885ALDH1A1 585/4885 |
| US-20040175434-A1 | Antimicrobial compositions | MRPL21, FPR1, ARG1 | CA2 4241/4885CA1 4744/4885ALDH1A1 2079/4885 |
| US-20110245226-A1 | PIPERIDINYL DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY | CCR1, CCR2, CCR3 | CA2 1930/4885CA1 1698/4885ALDH1A1 263/4885 |
| US-20110245343-A1 | ANTI-WRINKLE AGENTS | GLA, H1-4, H1-3 | CA2 2926/4885CA1 4797/4885ALDH1A1 2655/4885 |
| US-10676423-B2 | Structure and synthesis of highly fluorinated amino acid derivatives | PFAS, BCAT2, SLC7A1 | CA2 1936/4885CA1 456/4885ALDH1A1 3892/4885 |
| US-10626128-B2 | — | BACE1, APP, IAPP | CA2 1025/4885CA1 170/4885ALDH1A1 1095/4885 |
| US-20070167613-A1 | Process for the purification of antibodies | FCGR1A, FCGRT, CD47 | CA2 278/4885CA1 329/4885ALDH1A1 2803/4885 |
| US-20100317068-A1 | METHOD FOR PRODUCING SERINE DERIVATIVE AND PROTEIN USED FOR THE SAME | SPR, AMD1, DAO | CA2 3712/4885CA1 2871/4885ALDH1A1 202/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.